What Has Been The Evolution of the Iliac Stent Market in Recent Years?
The iliac stent market has seen considerable growth due to a variety of factors.
• The iliac stent market has grown steadily in recent years. It will increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a CAGR of 7.2%.
This growth is driven by the expansion of the global healthcare industry, rising awareness of minimally invasive procedures, increased demand for stenting, a rise in iliac artery disease, and improved healthcare infrastructure.
What Is the Forecasted Market Size and Growth Rate for The Iliac Stent Market Size In The Coming Years?
The iliac stent market is expected to maintain its strong growth trajectory in upcoming years.
• The iliac stent market is forecast to reach $1.43 billion by 2029, growing at a CAGR of 6.9%.
Growth is driven by the rising prevalence of peripheral artery diseases, an aging population, more angioplasty procedures, demand for minimally invasive treatments, and increased diabetes rates. Trends include technological advancements in iliac stents, more product approvals, medical technology advancements, expanding distribution networks, and iliac stents being adopted in outpatient settings.
What Factors Are Driving Growth In The Iliac Stent Market?
The increasing prevalence of peripheral artery diseases (PAD) is expected to drive the iliac stent market. PAD is caused by the narrowing or blockage of arteries, often due to conditions like smoking, hypertension, and diabetes. Iliac stents are used to improve blood flow in PAD patients, offering a minimally invasive treatment option. For instance, the Society for Cardiovascular Angiography And Interventions reported that PAD affects 8-10 million Americans annually, and this number is expected to rise to 19 million by 2050. The growing prevalence of PAD is contributing to the growth of the iliac stent market.
What Are The Main Segments Of The Global Iliac Stent Market?
The iliac stent market covered in this report is segmented –
1) By Type: Self-Expandable Stents, Balloon-Expandable Stents, Other Types
2) By Artery Lesions: Common Iliac Artery Lesions, Severe Calcified Lesions, Complete Obstructive Lesions
3) By End-Users: Hospitals, Outpatient Facilities, Other End-Users
Subsegments:
1) By Self-Expandable Stents: Nitinol Self-Expandable Stents, Polymer-Coated Self-Expandable Stents
2) By Balloon-Expandable Stents: Bare-Metal Balloon-Expandable Stents, Drug-Eluting Balloon-Expandable Stents
3) By Other Types: Covered Stents, Hybrid Stents
Pre-Book The Iliac Stent Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Iliac Stent Market?
Leading firms within the iliac stent sector, are working on groundbreaking products such as iCast, with the goal of enhancing patient outcomes and lowering complication risks. The iCast-covered stent system exhibits a novel strategy for the treatment of iliac artery occlusive disease, delivering improved functionality and diminished risks compared to standard bare-metal stents. For instance, in October 2023, Getinge, a healthcare establishment based in Sweden, publicized the commercial accessibility of the iCast-covered stent system in the USA, intended for the treatment of iliac arterial occlusive disease and approved by the Food and Drug Administration (FDA). This approval highlights Getinge's dedication to delivering premium products and support to U.S. clinicians and medical facilities as they strive to manage this serious ailment.
Who Are the Key Players In The Iliac Stent Market?
Major companies operating in the iliac stent market are:
• Cardinal Health Inc.
• Abbott Laboratories
• Medtronic Plc
• Becton
• Dickinson and Company
• Boston Scientific Corporation
• B. Braun Melsungen AG
• Terumo Corporation
• W. L. Gore & Associates Inc.
• C. R. Bard Inc.
• Getinge AB
• Cook Medical LLC
• Biotronik SE & Co. KG
• MicroPort Scientific Corporation
• Cordis Corporation
• Endologix Inc.
• LeMaitre Vascular Inc.
• Alvimedica
• Clearstream Technologies Ltd.
• Jotec GmbH
• Translumina GmbH
• Vascular Concepts Limited
• Lombard Medical Technologies
• Acandis GmbH
• Gore Medical
• Medizintechnik GmbH
What Is The Most Dominant Region In The Iliac Stent Market?
North America was the largest region in the iliac stent market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the iliac stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
